Haven't used GenomeNext yet?
Ask Trustburn

Questions about GenomeNext

Based on 11 reviews, listing data and website checks · updated 3 days ago

What is GenomeNext?

GenomeNext is a whole genome sequencing test solution launched by Ambry Genetics to improve diagnosis for rare diseases. It combines whole genome sequencing, RNA analysis, and ongoing reanalysis to address diagnostic challenges. The service is designed for individuals and healthcare providers seeking advanced genetic testing for rare conditions.

How does the GenomeNext process work?

The process involves combining whole genome sequencing with RNA analysis and performing ongoing reanalysis. This step-by-step approach ensures that potential genetic issues are thoroughly investigated and re-evaluated over time to improve diagnosis accuracy.

Which companies are behind GenomeNext?

Ambry Genetics, a wholly owned subsidiary of Tempus AI, Inc., launched GenomeNext to improve rare disease diagnosis. Tempus AI is a leader in clinical genomic testing, providing the backing and expertise for this new offering.

What do reviewers praise about GenomeNext?

Some reviewers praise GenomeNext for its outstanding service, exceptional support, and the talent and dedication of its team. Customers frequently mention that the company goes above and beyond to ensure satisfaction and provides top-notch expertise.

What do reviewers complain about GenomeNext?

Some reviewers note that while the benefits are good, there is not much room for growth and the pay could be better. Others mention that the work environment is decent but the overall experience is average for some employees.

How recent and how many are the reviews and what is the rating?

As of the latest reviews, the Trustburn rating is 4.1 out of 5 from 11 reviews. The rating split includes several 5-star reviews praising the service and team, alongside some 3-star reviews highlighting average growth opportunities and pay.

What do news sources say about GenomeNext?

News articles from 2026, such as those from RTTNews and BioSpace, highlight GenomeNext as a new offering from Ambry Genetics. These sources confirm the launch date and the purpose of the test solution to improve rare disease diagnosis.

Where is GenomeNext located?

GenomeNext is located in Aliso Viejo, Calif., as indicated by the press release from Ambry Genetics. The company operates under the umbrella of Tempus AI, Inc., which is listed on NASDAQ under the ticker TEM.

What is the official website of GenomeNext?

The official website of GenomeNext is genomenext.com.

Based on reviews, listing data and the company's website. Verify anything important with the company directly.

Mark Bodkevi
Reviews 1

GenomeNext is a company that truly values their employees. From the moment I joined, I felt welcomed and supported. The work environment is positive and collaborative. The management team is attentive and always available to help. I'm grateful to be a part of this organization.

Adrian Coman
Reviews 1

I had the pleasure of working with GenomeNext recently and I must say, they exceeded my expectations. The quality of their work is remarkable and their team is highly skilled. I would definitely work with them again in the future.

Questions & Answers

No questions yet — be the first to ask.

News & Press

No news yet. This is where the business shares its own updates and press.

Photos

No photos yet. Photos shared by reviewers will show up here.

Widgets

Boost your business trust by displaying widget on your website — its a simple way to convert your visitors into customers.

Embed code

<script src="https://trustburn.com/widgets/index.js"></script>
<div class="trustburn-widget" data-trustburn-protocol="https:" data-trustburn-domain="trustburn.com" data-trustburn-widget="score" data-company-path="genomenext-com" data-lang="en"></div>
More widgets

About GenomeNext